PLA–Inhibitor (stoPLA) – New class of NSAIDs for oral and transdermal inflammation treatment
PLA2 enzymes exist as secreted forms and cytosolic forms. The cytosolic or cPLA2 enzymes appear to play a key role in the pathway leading to the formation of platelet activating factor and eicosanoids. PLA2 enzymes cleave phospholipids at the sn-2-position. This metabolic step isinstrumental in a variety of pathogenic processes causingpain and inflammation.
Presently glucocorticoids are used for inhibition of PLA2. Unfortunately, glucocorticoids have serious side effectswhich limit their use as medication for inflammationtreatment.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 10
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Webb captures top of iconic horsehead nebula in unprecedented detail
NASA’s James Webb Space Telescope has captured the sharpest infrared images to date of a zoomed-in portion of one of the most distinctive objects in our skies, the Horsehead Nebula….
Cost-effective, high-capacity, and cyclable lithium-ion battery cathodes
Charge-recharge cycling of lithium-superrich iron oxide, a cost-effective and high-capacity cathode for new-generation lithium-ion batteries, can be greatly improved by doping with readily available mineral elements. The energy capacity and…
Novel genetic plant regeneration approach
…without the application of phytohormones. Researchers develop a novel plant regeneration approach by modulating the expression of genes that control plant cell differentiation. For ages now, plants have been the…